Live cell encapsulation Market - by Polymer Type (Natural {Alginate, Chitosan}, Synthetic), By Method (Microencapsulation, Macroencapsulation, Nanoencapsulation), By Application (Drug Delivery, Cell Transplantation) & Forecast, 2023 – 2032
Published Date: August - 2024 | Publisher: MIR | No of Pages: 240 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationLive cell encapsulation Market - by Polymer Type (Natural {Alginate, Chitosan}, Synthetic), By Method (Microencapsulation, Macroencapsulation, Nanoencapsulation), By Application (Drug Delivery, Cell Transplantation) & Forecast, 2023 – 2032
Live Cell Encapsulation Market Size
Hey there! The market for live cell encapsulation is pretty big, around 251 million bucks in 2022. And it's only going to get bigger, growing at a rate of over 3.8% every year until 2032. So, what exactly is live cell encapsulation? Well, it's basically putting living cells inside a protective shell. This is super useful, especially for cell-based therapies. Think of it as a way to deliver healing cells to the right spot in the body, while keeping them safe from the immune system's defenses. This kind of protection is a major bonus, which is why the demand for live cell encapsulation is going to keep climbing.
Moreover, increasing application of live cell encapsulation in the development of therapeutics for various chronic diseases such as cancer, diabetes, and autoimmune diseases is anticipated to promote the market growth during the forecast period. For instance, live cell encapsulation is utilised to give insulin-producing cells to diabetic patients and used to provide dopamine-producing cells to Parkinson's disease patients. Such factor will drive the market growth.
| Report Attribute | Details |
|---|---|
| Base Year | 2022 |
| Live cell encapsulation Market Size in 2022 | 251 Million USD |
| Forecast Period | 2023 to 2032 |
| Forecast Period 2023 to 2032 CAGR | 3.8% |
| 2032 Value Projection | 370 Million USD |
| Historical Data for | 2018 to 2022 |
| No. of Pages | 180 |
| Tables, Charts & Figures | 354 |
| Segments covered | Polymer Type, Method, Application, and Region |
| Growth Drivers |
|
| Pitfalls & Challenges |
|
Live cell encapsulation also known as cell encapsulation, is a technique where living cells are trapped into a beads/membrane, a selectively permeable polymeric material. This makes encapsulated cell a potential tool for the treatment of various human illnesses such as diabetes, Parkinson's disease, lysosomal storage disease (LSD), hemophilia, and cancer.
COVID-19 Impact
When COVID-19 hit, it turned out to be a game-changer for the live cell encapsulation market. The sudden outbreak sparked a frenzy of research and development as scientists raced to find treatments and vaccines using cutting-edge encapsulation technology. But here's the surprising twistthe pandemic also led to a surge in studies on organ damage caused by the virus. And guess what? Live cell encapsulation, a technique that uses tissue engineering to repair damaged tissue, stepped up to the plate to help treat these injuries. For example, researchers started using live cell encapsulation to treat liver damage after COVID-19 infections. It turned out that encapsulation could boost the survival and growth of liver cells, giving hope to patients with liver damage. So, ironically, the COVID-19 pandemic gave a boost to the live cell encapsulation market. The virus prompted researchers to explore new uses for encapsulation technology, and its potential in treating COVID-19-related complications became clearer than ever.
Live Cell Encapsulation Market Trends
As more people suffer from diseases that damage tissues, the need for tissue transplants is growing. But there aren't enough organs and tissues available, so scientists are developing new ways to grow them in the lab. One promising approach is using hydrogels to create a 3D environment for cells. This helps cells stay healthy and grow into tissues that are just like the ones in our bodies. Another way is to encapsulate live cells. This protects them from the body's immune system, which would normally reject them. This means that transplanted tissues are less likely to be rejected. As more diseases emerge that require tissue transplants, the market for regenerative medicine is expected to grow. And live cell encapsulation is expected to play a major role in this growth, as it offers a unique and effective way to treat a wide range of diseases.
Live Cell Encapsulation Market Restraint
Making tiny shells or bubbles to protect living cells can be pricey for a few reasons. First, building these tiny containers takes special tools and know-how, which don't come cheap. Second, the cells themselves are precious cargo. They need to be handled with extreme care, which adds to the time and cost of the process. Lastly, making these live cell-carrying containers safe and effective for use in humans requires a lot of testing and checking. This takes time and money too.
Live Cell Encapsulation Market Analysis
The cell encapsulation market is like a big pie, and it's divided into two slicesnatural and synthetic polymers. The natural slice is bigger, worth about 177.5 million dollars in 2022. Natural polymers are like giant molecules that come from nature. They're good for cell encapsulation because they're safe, break down easily, grow back, and don't upset the body. They can come from animals, plants, or even bacteria. These natural polymers are like friendly neighbors to cells and tissues. They get along well because they speak the same language. So, natural polymers can help deliver things like vitamins, medicines, or other important substances to cells and tissues in a way that the body won't reject.
When it comes to keeping live cells alive outside the body, there are three main ways to do itmicroencapsulation, macroencapsulation, and nanoencapsulation. Right now, the most popular method is microencapsulation, which is used to create tiny capsules that hold living cells. These capsules are small, only 1 to 1000 micrometers in diameter, so they can easily deliver drugs or protect cells from harm. Microencapsulation is particularly useful for treating diseases like cancer, tuberculosis, arthritis, diabetes, and respiratory infections. For example, doctors can take cells from the pancreas called islet cells and put them inside microcapsules to help people with diabetes. This way, the cells can safely release insulin into the body without being attacked by the immune system. As more and more treatments use microencapsulation, the market for this technology is expected to grow even more in the coming years.
Depending on what it's used for, the live cell encapsulation market can be divided into four main segmentsdrug delivery, regenerative medicine, cell transplantation, and other applications. In 2022, the drug delivery segment took the lion's share of the market. And it's expected to keep growing at a steady clip of 4.3% from 2023 to 2032. Live cell encapsulation is a cool technique that's being used to make all kinds of drug delivery systems, like tablets, capsules, and injections. It's a great way to get drugs to where they need to go in the body. Controlled drug delivery can make a big difference in treating diseases that tend to get worse over time. By using live cell encapsulation to control drug delivery, we can lower the dose of medication needed, make it work better, make it easier for patients to take, and reduce side effects. That's what's really driving the growth of this segment. Plus, researchers are working hard to show that live cell encapsulation is safe and effective, which is only going to make the market grow even more in the years to come.
In 2022, the market for live cell encapsulation in the US reached a whopping $79.4 million. Why the big boom? One worddiabetes. Diabetes is a major player in the US, with over 37 million people affected. That's like one out of every nine people! And here's the kickerover 8 million of those folks don't even know they have it. It's especially common among seniors, with nearly 30% of people over 65 battling diabetes. This growing number of diabetes cases has companies in the live cell encapsulation market jumping for joy. Why? Because they've got a potential game-changer on their hands. Live cell encapsulation can deliver new drugs to treat diabetes, giving hope to millions of people. So, get ready for this market to keep growing and making a difference in the fight against diabetes.
Additionally, presence of key operating players coupled with increasing clinical trial studies for product launch will supplement the regional growth. For instance, in February 2021, ViaCyte, Inc. announced the initiation of phase 2 clinical study of encapsulated cell therapy for type 1 diabetes patients. Such factor is expected to proliferate the regional market growth.
Live Cell Encapsulation Market Share
Some of the major market players operating in the live cell encapsulation market are
- Austrianova
- Merck KGaA
- Sphere Fluidics Limited
- Blacktrace Holdings Ltd
- BIO INX
- Isogen
These players focus on strategic partnerships, new product launch & commercialization for market expansion. Furthermore, these players are heavily investing in research that allows them to introduce innovative products and garner maximum revenue in the market.
Live Cell Encapsulation Industry News
- In March 2023, SG Austria (Austrianova) announced that Checkmate Capital Group, a multi-family investment and advisory group based in California, has made a preferred equity investment in SG Austria, the parent company of Austrianova. This investment helped the company to expand and grow.
- In November 2022, BIO INX launched Hydrobio INX N400, the first commercially available bioresin enabling live cell encapsulation in healthcare 3D printing with Nanoscribe’s two-photon polymerization technology. This strategy helped the company to expand their product portfolio and customer base.
The live cell encapsulation market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 to 2032, for the following segments
Click here to Buy Section of this Report
By Polymer Type
- Natural Polymers
- Alginate
- Chitosan
- Cellulose
- Others
- Synthetic Polymers
By Method
- Microencapsulation
- Macroencapsulation
- Nanoencapsulation
By Application
- Drug Delivery
- Regenerative Medicine
- Cell Transplantation
- Other Applications
The above information is provided for the following regions and countries
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Poland
- Switzerland
- Netherlands
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Thailand
- Indonesia
- Vietnam
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Argentina
- Chile
- Colombia
- Peru
- Rest of Latin America
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Israel
- Rest of MEA
Related Reports
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy